Multienter nationwide studY to assesS diagnosis and managemenT in patients with systemic and Isolated Cardiac Sarcoidosis : Prospective Registry

MYSTICS-PRO - Multienter nationwide studY to assesS diagnosis and managemenT in patients with systemic and Isolated Cardiac Sarcoidosis : Prospective Registry

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000053942

Enrollment

320

Registered

2024-03-25

Start date

2024-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Sarcoidosis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who meet the folloing 3 criteria, 1) patients who are older than 18 years 2) patients who are newly diagnosed as cardiac sarcoidosis (*) 3) patients who give a document consent

Exclusion criteria

Exclusion criteria: patients who are judged as inappropriate for the enrollment by investigators

Design outcomes

Primary

Measure	Time frame
Cardiac death, heart failure hospitalization or fatal ventricular arrhythmia events	—

Secondary

Measure	Time frame
1. Relapsing cardiac sarcoidosis(positive findings of FDG-PET or Ga scintigraphy at 12 months after initiation of immunosuppressive therapy) 2. Cardiac death 3. All-cause death 4. Fatal ventricular arrhythmia event 5. Heart failure hospitalization etc	—

Countries

Japan

Contacts

Public ContactChisato Izumi

National Cerebral and Cardiovascular Center Department of Heart Failure and Transplant

izumi-ch@ncvc.go.jp0661701070

Outcome results